Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARα/γ dual agonist, attenuates molecular pathological alterations in learning memory in AD mice

References

• Di Lazzaro V. Emergence of neurophysiological biomarkers of Alzheimer disease. J Neurol Neurosurg Psychiatry. 2018;89(12):1235. doi: 10.1136/jnnp-2018-318867
   PubMed Web of Science ®Google Scholar
• Guo T, Zhang D, Zeng Y, et al. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease. Mol Neurodegener. 2020;15(1):40. doi: 10.1186/s13024-020-00391-7
   PubMed Web of Science ®Google Scholar
• Halima SB, Mishra S, Raja KMP, et al. Specific inhibition of β-secretase processing of the Alzheimer disease amyloid precursor protein. Cell Rep. 2016;14(9):2127–2141. doi: 10.1016/j.celrep.2016.01.076
   PubMed Web of Science ®Google Scholar
• Xiong, J., Kang, S. S., Wang, Z., et al. FSH blockade improves cognition in mice with Alzheimer’s disease. Nature. 2022;603(7901):470–476. doi: 10.1038/s41586-022-04463-0
   PubMed Web of Science ®Google Scholar
• Neumann U, Ufer M, Jacobson LH, et al. The BACE -1 inhibitor CNP 520 for prevention trials in Alzheimer’s disease. EMBO Mol Med. 2018;10(11):e9316. doi: 10.15252/emmm.201809316
   PubMed Web of Science ®Google Scholar
• Ribaudo G, Coghi P, Zanforlin E, et al. Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer’s disease. Bioorg Chem. 2019;87:474–483. doi: 10.1016/j.bioorg.2019.03.034
   PubMed Web of Science ®Google Scholar
• Musardo S, Therin S, Pelucchi S, et al. The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer’s disease. Mol Ther. 2022;30(7):2474–2490. doi: 10.1016/j.ymthe.2022.03.024
   PubMed Web of Science ®Google Scholar
• Pramanik S, Sulistio YA, Heese K. Neurotrophin Signaling and Stem Cells—Implications for Neurodegenerative Diseases and Stem Cell Therapy. Mol Neurobiol. 2017;54(9):7401–7459. doi: 10.1007/s12035-016-0214-7
   PubMed Web of Science ®Google Scholar
• Fleitas C, Piñol-Ripoll G, Marfull P, et al. proBDNF is modified by advanced glycation end products in Alzheimer’s disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing. Mol Brain. 2018;11(1):68. doi: 10.1186/s13041-018-0411-6
   PubMedGoogle Scholar
• Choi, J., Kwon, H. J., Lee, J. E., et al. Hyperoxygenation revitalizes Alzheimer’s disease pathology through the upregulation of neurotrophic factors. Aging Cell. 2019;18(2):e12888. doi: 10.1111/acel.12888
   PubMed Web of Science ®Google Scholar
• Li, Y., Xu, L., Zeng, K, et al. Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARα/γ dual agonist, protects against ischemia-induced brain damage in mice by inhibiting inflammatory responses. Brain Behav Immun. 2017;66:289–301. doi: 10.1016/j.bbi.2017.07.015
   PubMed Web of Science ®Google Scholar
• Luo D, Zhang Y, Yuan X, et al. Oleoylethanolamide inhibits glial activation via moudulating PPARα and promotes motor function recovery after brain ischemia. Pharmacol Res. 2019;141:530–540. doi: 10.1016/j.phrs.2019.01.027
   PubMed Web of Science ®Google Scholar
• Harmon GS, Lam MT, Glass CK. Ppars and lipid ligands in inflammation and metabolism. Chem Rev. 2011;111(10):6321–6340. doi: 10.1021/cr2001355
   PubMed Web of Science ®Google Scholar
• Xie, Z., Zhao, J., Wang, H., et al. Magnolol alleviates Alzheimer’s disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-γ. Biomed Pharmacother = Biomed Pharmacotherapie. 2020;124:109886. doi: 10.1016/j.biopha.2020.109886
   PubMed Web of Science ®Google Scholar
• Ren J, Zhang S, Wang X, et al. MEF2C ameliorates learning, memory, and molecular pathological changes in Alzheimer’s disease in vivo and in vitro. Acta Biochim Biophys Sin (Shanghai). 2022;54(1):77–90. doi: 10.3724/abbs.2021012
   PubMed Web of Science ®Google Scholar
• Li Y, Ren T, Xu L, et al. Propane-2-sulfonic acid octadec-9-enyl-amide, a novel peroxisome proliferator-activated receptors α and γ dual agonist, enhances hippocampal neurogenesis and neuroplasticity in rats with cerebral ischaemia. Neuroreport. 2019;30(18):1299–1306. doi: 10.1097/WNR.0000000000001360
   PubMed Web of Science ®Google Scholar
• Li Y, Xu L, Zeng K, et al. Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARalpha/gamma dual agonist, protects against ischemia-induced brain damage in mice by inhibiting inflammatory responses. Brain Behav Immun. 2017;66:289–301. doi: 10.1016/j.bbi.2017.07.015
   PubMed Web of Science ®Google Scholar
• Zhong L, Sheng X, Wang W, et al. TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration. Immunity. 2023;56(8):1794–1808.e8. doi: 10.1016/j.immuni.2023.06.016
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. doi: 10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611–622. doi: 10.1373/clinchem.2008.112797
   PubMed Web of Science ®Google Scholar
• Zhuo R, Song Z, Wang Y, et al. Oleoylethanolamide ameliorates motor dysfunction through PPARα-mediates oligodendrocyte differentiation and white matter integrity after ischemic stroke. Phytother Res. 2023;37(11):5341–5353. doi: 10.1002/ptr.7970
   PubMed Web of Science ®Google Scholar
• Ren XQ, Huang X, Xing SY, et al. Neuroprotective effects of novel compound FMDB on cognition, neurogenesis and apoptosis in APP/PS1 transgenic mouse model of Alzheimer’s disease. Neurochem Int. 2023;165:105510. doi: 10.1016/j.neuint.2023.105510
   PubMed Web of Science ®Google Scholar
• Bothwell M. NGF, BDNF, NT3, and NT4. Handb Exp Pharmacol. 2014;220:3–15.
   PubMedGoogle Scholar
• Mitsui T, Fischer I, Shumsky JS, et al. Transplants of fibroblasts expressing BDNF and NT-3 promote recovery of bladder and hindlimb function following spinal contusion injury in rats. Exp Neurol. 2005;194(2):410–431. doi: 10.1016/j.expneurol.2005.02.022
   PubMed Web of Science ®Google Scholar
• Ridler C. Alzheimer disease: BACE1 inhibitors block new Aβ plaque formation. Nat Rev Neurol. 2018;14(3):126. doi: 10.1038/nrneurol.2018.12
   Google Scholar
• Lu H, Zhang H, Cong Y, et al. Propane-2-sulfonic acid octadec-9-enyl-amide, a novel PPARα/γ dual agonist, reverses neuroinflammation in lipopolysaccharide-induced mice. Neuroreport. 2020;31(15):1096–1103. doi: 10.1097/WNR.0000000000001521
   PubMed Web of Science ®Google Scholar
• Li Y, Lu H, Xie S, et al. Propane-2-sulfonic acid octadec-9-enyl-amide alleviates scopolamine-induced spatial learning and memory deficits in mice. Biochem Biophys Res Commun. 2020;529(2):283–288. doi: 10.1016/j.bbrc.2020.03.110
   PubMed Web of Science ®Google Scholar
• Wang YX. Ppars: diverse regulators in energy metabolism and metabolic diseases. Cell Res. 2010;20(2):124–137. doi: 10.1038/cr.2010.13
   PubMed Web of Science ®Google Scholar
• Agarwal, S., Yadav, A., & Chaturvedi, R. K. Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders. Biochem Biophys Res Commun. 2017;483(4):1166–1177. doi: 10.1016/j.bbrc.2016.08.043
   PubMed Web of Science ®Google Scholar
• Zhou, H., Yang, W. S., Li, Y., et al. Oleoylethanolamide attenuates apoptosis by inhibiting the TLR4/NF-κB and ERK1/2 signaling pathways in mice with acute ischemic stroke. Naunyn-Schmiedeberg’s Arch Pharmacol. 2017;390(1):77–84. doi: 10.1007/s00210-016-1309-4
   Google Scholar
• Ivraghi MS, Zamanian MY, Gupta R, et al. Neuroprotective effects of gemfibrozil in neurological disorders: Focus on inflammation and molecular mechanisms. CNS Neurosci Ther. 2023. doi:10.1111/cns.14473.
   PubMed Web of Science ®Google Scholar
• Raha S, Ghosh A, Dutta D, et al. Activation of PPARα enhances astroglial uptake and degradation of β-amyloid. Sci Signal. 2021;14(706):eabg4747. doi: 10.1126/scisignal.abg4747
   PubMed Web of Science ®Google Scholar
• Luo R, Su LY, Li G, et al. Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model. Autophagy. 2020;16(1):52–69. doi: 10.1080/15548627.2019.1596488
   PubMed Web of Science ®Google Scholar
• Moosecker S, Gomes P, Dioli C, et al. Activated PPARgamma abrogates misprocessing of amyloid precursor protein, tau missorting and synaptotoxicity. Front Cell Neurosci. 2019;13:239. doi: 10.3389/fncel.2019.00239
   PubMed Web of Science ®Google Scholar
• Quan Q, Qian Y, Li X, et al. Pioglitazone reduces β amyloid levels via inhibition of PPARγ phosphorylation in a neuronal model of Alzheimer’s disease. Front Aging Neurosci. 2019;11:178. doi: 10.3389/fnagi.2019.00178
   PubMed Web of Science ®Google Scholar
• Sandeep Ganesh G, Konduri P, Kolusu AS, et al. Neuroprotective effect of Saroglitazar on scopolamine-induced Alzheimer’s in rats: insights into the underlying mechanisms. ACS Chem Neurosci. 2023;14(18):3444–3459. doi: 10.1021/acschemneuro.3c00320
   PubMed Web of Science ®Google Scholar
• Sawangjit, A., Oyanedel, C. N., Niethard, N., et al. The hippocampus is crucial for forming non-hippocampal long-term memory during sleep. Nature. 2018;564(7734):109–113. doi: 10.1038/s41586-018-0716-8
   PubMed Web of Science ®Google Scholar
• Vandal M, White PJ, Tremblay C, et al. Insulin reverses the high-fat diet–induced increase in brain Aβ and improves memory in an animal model of Alzheimer disease. Diabetes. 2014;63(12):4291–4301. doi: 10.2337/db14-0375
   PubMed Web of Science ®Google Scholar
• Vassar R, Cole SL. The basic biology of BACE1: a key therapeutic target for Alzheimer’s disease. Curr Genomics. 2007;8(8):509–530. doi: 10.2174/138920207783769512
   PubMed Web of Science ®Google Scholar
• Zhu D, Montagne A, Zhao Z. Alzheimer’s pathogenic mechanisms and underlying sex difference. Cell Mol Life Sci. 2021;78(11):4907–4920. doi: 10.1007/s00018-021-03830-w
   PubMed Web of Science ®Google Scholar
• Tremblay C, Choudhury P, Belden CM, et al. The role of sex differences in depression in pathologically defined Alzheimer’s disease. Front Aging Neurosci. 2023;15:1156764. doi: 10.3389/fnagi.2023.1156764
   PubMed Web of Science ®Google Scholar